{
    "id": 893,
    "fullName": "BRAF V600M",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRAF V600M (previously reported as V599) lies within the activation segment of the kinase domain of the Braf protein (PMID: 15035987). V600M results in intermediate Braf kinase activity in cell culture (PMID: 28783719), and in one of two cell lines increased cell proliferation and cell viability compared to wild-type Braf (PMID: 29533785), and is therefore predicted to confer a gain of function to the Braf protein.",
            "references": [
                {
                    "id": 9692,
                    "pubMedId": 28783719,
                    "title": "Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28783719"
                },
                {
                    "id": 146,
                    "pubMedId": 15035987,
                    "title": "Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15035987"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 673,
        "geneSymbol": "BRAF",
        "terms": [
            "BRAF",
            "B-raf",
            "B-RAF1",
            "BRAF1",
            "NS7",
            "RAFB1"
        ]
    },
    "variant": "V600M",
    "createDate": "07/07/2014",
    "updateDate": "09/11/2018",
    "referenceTranscriptCoordinates": {
        "id": 109426,
        "transcript": "NM_004333",
        "gDna": "chr7:g.140753337C>T",
        "cDna": "c.1798G>A",
        "protein": "p.V600M",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20141,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, Zelboraf (vemurafenib) treatment resulted in a objective response rate of 44.8% (43/96), median duration of response of 6.4 months, median progression-free survival (PFS) of 5.2 months, and median overall survival of 10 months in non-small cell lung cancer patients with BRAF V600 mutations, with a PFS of 5.9 months in the patient harboring BRAF V600M (PMID: 31959346; NCT02304809).",
            "molecularProfile": {
                "id": 985,
                "profileName": "BRAF V600M"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17717,
                    "pubMedId": 31959346,
                    "title": "Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31959346"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 985,
            "profileName": "BRAF V600M",
            "profileTreatmentApproaches": [
                {
                    "id": 2190,
                    "name": "MEK1 Inhibitor",
                    "profileName": "BRAF V600M"
                },
                {
                    "id": 2191,
                    "name": "MEK2 Inhibitor",
                    "profileName": "BRAF V600M"
                },
                {
                    "id": 2188,
                    "name": "BRAF Inhibitor",
                    "profileName": "BRAF V600M"
                },
                {
                    "id": 2189,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "BRAF V600M"
                },
                {
                    "id": 2192,
                    "name": "RAF Inhibitor (Pan)",
                    "profileName": "BRAF V600M"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 109425,
            "transcript": "XM_005250045",
            "gDna": "chr7:g.140753337C>T",
            "cDna": "c.1798G>A",
            "protein": "p.V600M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 109426,
            "transcript": "NM_004333",
            "gDna": "chr7:g.140753337C>T",
            "cDna": "c.1798G>A",
            "protein": "p.V600M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}